Encompass Health (Encompass Health) GF Value

: $68.79 (As of Today)

View and export this data going back to 1989. Start your Free Trial

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-19), Encompass Health's share price is $79.295. Encompass Health's GF Value is $68.79. Therefore, Encompass Health's Price-to-GF-Value for today is 1.15.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Encompass Health is Modestly Overvalued.

Encompass Health (NYSE:EHC) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Encompass Health's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	79.295	/	68.79
	=	1.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encompass Health GF Value Related Terms

Thank you for viewing the detailed overview of Encompass Health's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Encompass Health (Encompass Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Encompass Health Corp (NYSE:EHC) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

HSOA:Germany

Address

9001 Liberty Parkway, Birmingham, AL, USA, 35242

Website

https://www.encompasshealth.com

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Executives

Douglas E Coltharp	officer: EVP, Chief Financial Officer	C/O UNDER ARMOUR, INC., 1020 HULL STREET, BALTIMORE MD 21230
Elissa Joy Charbonneau	officer: Chief Medical Officer	24 HAWTHORNE CIRCLE, YARMOUTH ME 04096
Mark J Tarr	officer: Executive VP Operations	C/O ENCOMPASS HEALTH CORPORATION, 9001 LIBERTY PARKWAY, BIRMINGHAM AL 35242
Greg D Carmichael	director
Kevin J. O'connor	director	13995 PASTEUR BOULEVARD, PALM BEACH GARDENS FL 33418
Terrance Williams	director	7184 BIDDICK, NEW ALBANY OH 43054
Christopher R Reidy	director	ONE ADP BLVD, ROSELAND NJ 07068
Andrew L Price	officer: Interim Chief Accting Officer	3660 GRANDVIEW PARKWAY, SUITE 200, BIRMINGHAM AL 35243
Barbara Ann Jacobsmeyer	officer: EVP, Operations	2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Donald L Correll	director	C/O INTERCHANGE FINANCIAL SERVICES CORP, PARK 80 W PLAZA TWO, SADDLE BROOK NJ 07663
Anthony April Kaye Bullock	officer: CEO and President, Encompass	3606 PRINCETON AVENUE, DALLAS TX 75205
Higdon Leo I Jr	director	1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Patricia Anne Maryland	director	7342 HORIZON DRIVE, WEST PALM BEACH FL 33412
Yvonne M Curl	director	C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Cheryl B. Levy	officer: Chief Human Resources Officer	3137 BROOK HIGHLAND DRIVE, BIRMINGHAM AL 35242